![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, November 13, 2019 7:23:04 PM
Kathryn Packman
Sr. Scientific Director and Global Head of Tumor Biology at Janssen Pharmaceutical Companies of Johnson & Johnson
PS Targeting is HUGE ...is that not why Joseph Carleone was brought on board as Chair?
I didn't realize the patent was published with Kathryn Packman ...and others including Kelli J Glenn at SK Holdings
Some reading for the evening ....
________
PPHM - Peregrine Pharmaceuticals ...now being called Avid Bioservices CDMO had Chair of BOD Joseph Carleone and sat on AMPAC Fine Chemicals Board till August 2018 though Avid website still shows him Chair at AMPAC....which was shifted from HIG Capital to SK Holdings (which had lots of subsidiaries ...) including ties to Kelli Glenn at SK Life Sciences
___________
Joseph Carleone, Ph.D.
Chairman of the Board
Dr. Carleone is Chairman of the Board of AMPAC Fine Chemicals LLC, a leading manufacturer of pharmaceutical active ingredients.
....
....
http://ir.avidbio.com/board-directors/joseph-carleone
___________
Together AMPAC Fine Chemicals (USA) and SK biotek (South Korea and Ireland) offer an expanded value proposition in the worldwide CDMO space.
....
....
AMPAC Fine Chemicals â??AFCâ?? (recently acquired by SK Holdings) and SK biotek now offer expanded CDMO services across three continents, and with six manufacturing sites and one dedicated Analytical Testing facility, offer comprehensive capabilities that support all phases of drug development and commercialization.
https://ampacanalytical.com/wp-content/uploads/2018/11/AMPAC_SK-Fine-Chemicals.pdf
___________
SK life sciences a subsidiary of sk biopharmaceuticals
FDA accepts NDA for cenobamate
https://www.sklifescienceinc.com/about-us.html#/leadership
_________
AMPAC from HIG Capital to SK Holdings Corp( largest Korean Pharma deal)
July 16 2018
https://www.prnewswire.com/news-releases/ampac-fine-chemicals-to-be-acquired-by-sk-holdings-300680838.html
_________
Kelli J Glenn
Head of Toxicology/DMPK at SK Life Science
SK Life Science, Inc.
The Ohio State University
Greater New York City Area
487 connections
About
Toxicology, DMPK, and Bioanalytical department head who leads a group of dedicated scientists in developing drugs from Phase I through post-market. DMPK and bioanalytical subject matter expert (SME) for all development programs within the company.
...
...
Patents
Method for administration of an anti tumor agent
Issued September 26, 2013
United StatesWO2013139687 A1
There is provided a new pharmaceutical product comprising Compound (A) characterized by a dosage regimen which maximizes anti-tumor activity while maintaining acceptable toxicity levels.
There is provided a new pharmaceutical product comprising Compound (A) characterized by a dosage regimen which maximizes anti-tumor activity while maintaining acceptable toxicity levels.
Other inventors
Brian Higgins
Kathryn Packman
Gwen Nichols
...
...
https://www.linkedin.com/in/kelliglenn
__________
Patents by Inventor Kathryn Packman
Kathryn Packman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
METHOD FOR ADMINISTRATION
Publication number: 20190328708
Abstract: There is provided a new dosage regimen for Compound A which maximizes anti-tumor activity while maintaining acceptable toxicity levels.
Type: Application
Filed: July 12, 2019
Publication date: October 31, 2019
Inventors:
Kelli Glenn,
Brian Higgins,
Gwen Nichols,
Kathryn Packman
...
...
https://patents.justia.com/inventor/kathryn-packman
____________
Recent CDMO News
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM